FDAapprovalDate

4 triples
GPTKB property

Random triples
Subject Object
gptkb:Vyndamax 2019-05-03
gptkb:Zulresso 2019
gptkb:Dupixent_(dupilumab) 2017
gptkb:Venclexta 2016